SciSparc Ltd. SPRC has been granted an approval from the Federal Institute for Drugs and Medical Devices in Germany (“BfArM”) for its phase IIb clinical trial to use SCI-110 for treating adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results